18Feb 2017

PHARMACOKINETICS OF BIO-THERAPEUTICS: Rituximab

Crossref Cited-by Linking logo
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author
  1. JoséeGolay, GianpietroSemenzato, Alessandro Rambaldi, Robin FoàGianlucaGaidano, (2013) Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics, mAbs, 5:6, 826-837, DOI: 10.4161/mabs.26008
  2. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, Meng YG, Mulkerrin MG. Mapping of the C1q binding site on rituxan, a chimericantibody with a human IgG1 Fc. J Immunol2000; 164:4178-84; PMID:10754313
  3. Lobo ED, Hansen RJ, Balthasar JP. Antibody pharmacokinetic and pharmacodynamics. J Pharm Sci 2004; 93:2645-68; PMID:15389672; http://dx.doi. org/10.1002/jps.20178
  4. Kagan L, Turner MR, Balu-Iyer SV, Mager DE. Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in rats. Pharm Res 2012; 29:490-9; PMID:21887597; http://dx.doi. org/10.1007/s11095-011-0578-3.
 

[Parbhat Saini. (2017); PHARMACOKINETICS OF BIO-THERAPEUTICS: Rituximab Int. J. of Adv. Res. 5 (Feb). 725-733] (ISSN 2320-5407). www.journalijar.com

Parbhat Saini
Birla Institute of Technology and Science,PIlani,Rajasthan

DOI:

Article DOI: 10.21474/IJAR01/3208      
DOI URL: http://dx.doi.org/10.21474/IJAR01/3208

Download Full Paper

Download PDF No. of Downloads: 12 | No. of Views: 68